Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,166.00
Bid: 12,164.00
Ask: 12,168.00
Change: -4.00 (-0.03%)
Spread: 4.00 (0.033%)
Open: 12,114.00
High: 12,258.00
Low: 12,114.00
Prev. Close: 12,170.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LIVE MARKETS-Europe's shares slide, but still set for weekly gains

Fri, 24th Sep 2021 08:28

Sept 24 - Welcome to the home for real-time coverage of markets brought to you by Reuters
reporters. You can share your thoughts with us at markets.research@thomsonreuters.com

EUROPE'S SHARES SLIDE, BUT STILL SET FOR WEEKLY GAINS (0725 GMT)

European shares are falling amid concerns about the fate of embattled property developer
China Evergrande Group and a sudden spike in bond yields. But after three days of strong
performance, the STOXX 600 is still set for weekly gains.

The top fallers this morning are sport clothing brands and retailers Adidas, Puma
and JD Sports after rival Nike reported a Q4 results miss and cut its
FY 2022 sales expectations due to a supply chain crunch brought in by months-long factory
closures in Vietnam.

On a brighter note, shares in Astrazeneca rise around 3% after the company reported
positive results from the PROpel Phase III trial.

(Joice Alves)

*****

MOVE OVER EVERGRANDE, TIME TO WATCH SOARING BOND YIELDS (0705 GMT)

World markets remain on edge on Friday as simmering concerns about the fate of embattled
property developer China Evergrande Group and a sudden spike in bond yields remind investors
that the final quarter of 2021 will be tricky to navigate.

European and U.S. stock futures fluctuated between gains and losses after U.S. stocks posted
their biggest two-day rise since July.

While a large part of those gains can be attributed to easing concerns about Evergrande
contagion, Thursday's spike in yields in the global $60 trillion plus government debt markets
raised the prospects of tighter monetary policy sooner than later.

Long-term U.S. Treasury yields have surged the most in 18 months as traders brought forward
expectations for the first Fed rate hike to the end of 2022 and the Bank of England opened the
door to a 2021 rate increase -- sparking the biggest jump in two-year UK gilt yields since March
2015.

Yield curves from Australia to Germany bear steepened in response and the dollar sprung to
the top of its 2021 trading range. While it remains to be seen whether the rise in yields can be
sustained, some signs of weakness can be detected in the “buy the dip” trade from investors.

Value stocks, a beneficiary of higher yields, outperformed growth ones on Thursday while
FAANG stocks have underperformed broader markets so far this month. And if investors are hoping
quiet weekend, think again.

Sunday's election in powerhouse European economy Germany will provide food for thought as
Chancellor Angela Merkel steps down after 16 years in charge.

Her successor will play a new role in shaping domestic and broader EU policy and have to
steer Germany's economy through a still uncertain post-COVID environment.

Thursday's flash PMIs for September pointed to a sharp slowdown in economic activity from
the previous month from rising energy prices and difficulty in sourcing parts and materials,
headwinds that are unlikely to abate in the coming days.

Key developments that should provide more direction to markets on Friday:

- ECB's Lagarde says many causes of inflation spike temporary: CNBC

- Nike warns on holiday delays, cuts full-year sales estimate

- Daimler's Mercedes-Benz to take a 33% stake in battery cell manufacturer
Automotive Cells Company

- Germany's IFO survey for September

- Fed speaker corner: Powell, Clarida

(Saikat Chatterjee)

*****

EUROPE SET FOR WEEKLY GAINS (0635 GMT)

Futures are pointing to a flat open for European bourses but the STOXX 600 is set for strong
weekly gains, with analysts saying investors bought the dip this week after a sharp Monday fall,
amid uncertainty around the fate of debt-ridden China Evergrande.

The risk on sentiment was also supported by a rate hike by the Norwegian central bank and
hawkish remarks from the Bank of England reinforced market expectations that the Federal Reserve
would begin tapering by year end.

Capping the enthusiasm, property developer Evergrande missed an interest payment deadline on
Thursday and has entered a 30-day grace period.

(Joice Alves)

*****

More News
Today 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
Today 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more
25 Apr 2024 09:18

TOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growth

(Alliance News) - AstraZeneca PLC on Thursday hailed the potential of its drugs pipeline as it delivered impressive growth in sales and profit in the first quarter.

Read more
25 Apr 2024 09:12

LONDON MARKET OPEN: Anglo American jumps on takeover bid from BHP

(Alliance News) - Stock prices in London opened mixed on Thursday, as investors cautiously eye data on the health of the US economy.

Read more
25 Apr 2024 08:38

AstraZeneca blows past analysts' estimates for Q1

(Sharecast News) - AstraZeneca posted better-than-expected revenues and profit for the first quarter of 2024 with both the company and analysts highlighting its drug pipeline.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.